26 BIBLIOGRAFIA
1.Come cambia l’epidemiologia del tumore della mammella in Italia. I risultati del progetto IMPATTO dei programmi di screening mammografico IMPACT Working Group. IMPACT Working Group, Pacini editore, 2011
2. Veronesi U, Salvadori B, Luini A, Banfi A, Zucali R, Del Vecchio M, et al. Conservative treatment of early breasc cancer. Long-‐term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg Mar 1990;211(3):250e9.
3. Roostaeian J, Crisera C. Current options in breast reconstruction with or without radiotherapy. Curr Opin Obstet Gynecol Feb 2011;23(1):44e50.
4. Doing More: Trends in Breast Cancer Surgery, 2005 to 2011. Lucas, Donald J.; Sabino, Jennifer; Shriver, Craig D.; Pawlik, Timothy M.; Singh, Devinder P.; Vertrees, Amy E. The American Surgeon, Volume 81, Number 1, January 2015, pp. 74-‐80(7)Southeastern Surgical Congress
5. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative ra-‐ diotherapy in high-‐risk postmenopausal breast-‐cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353: 1641–1648.
6. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-‐ risk breast cancer receiving adjuvant chemotherapy: 20-‐year results of the British Columbia ran-‐ domized trial. J Natl Cancer Inst 2005;97:116–126.
7. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-‐risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med 1997;337: 949–955.
8. Van de Steene J, Soete G, Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: The miss-‐ ing link. Radiother Oncol 2000;55:263–272.
9. Early Breast Cancer Trialists’ Collaborative Group. Favourable and unfavourable effects on long-‐term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 2000;355:1757–1770.
10. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med 1995;333:1444–1455.
11. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-‐year survival: An overview of the rand-‐ omised trials. Lancet 2005;366:2087–2106.
12. Strom EA, Woodward WA, Katz A, et al. Clinical investigation: Regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:1508–1513.
13. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiother-‐ apy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1539–1569.
27
14. Galper S, Recht A, Silver B, et al. Factors associated with re-‐ gional nodal failure in patients with early stage breast cancer with 0–3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys 1999;45:1157–1166.
15. Truong PT, Olivotto IA, Whelan TJ, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-‐mastectomy radiotherapy. CMAJ 2004;170:1263–73.
16. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1539–69.
17. Harris JR, Halpin-‐Murphy P, McNeese M, Mendenhall NP, Morrow M, Robert NJ. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 1999;44:989– 90.
18. Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Study of failure pattern among high-‐risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-‐term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol May 20 2006;24(15):2268e75.
19. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol J Eur Soc Ther Radiol Oncol Mar 2007;82(3):247e53.
20. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiother-‐ apy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1539–1569.
21. Galper S, Recht A, Silver B, et al. Factors associated with re-‐ gional nodal failure in patients with early stage breast cancer with 0–3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys 1999;45:1157–1166.
22. Sartor CI. Postmastectomy radiotherapy in women with breast cancer metastatic to one to three axillary lymph nodes. Curr Oncol Rep 2001;3:497–505.
23. Pierce LJ. The use of radiotherapy after mastectomy: A review of the literature. J Clin Oncol 2005;23:1706–1717.
24. Estrogen Receptor, Progesterone Receptor, HER-‐2, and Response to Postmastectomy Radiotherapy in High-‐Risk Breast Cancer: The Danish Breast Cancer Cooperative Group
Marianne Kyndi, Flemming B. Sørensen, Helle Knudsen, Marie Overgaard, Hanne Melgaard Nielsen, and Jens Overgaard Clin Oncol 26:1419-‐1426. © 2008 by American Society of Clinical Oncology
25. McCready DR, Chapman JA, Hanna WM, Kahn HJ, Murray D, Fish EB, et al. Factors affecting distant disease-‐free survival for primary invasive breast cancer: use of a log-‐normal survival model. Ann Surg Oncol 2000; 7: 416-‐26.
26. Trovo M, Durofil E, Polesel J, Roncadin M, Perin T, Mileto M, et al. Locoregional failure in early-‐stage breast cancer patients treated with radical mastectomy and adjuvant systemic
28
therapy: Which patients benefit from postmastectomy irradiation? Int J Radiat Oncol Biol Phys 2012; 83: e153-‐e157
27. Karlsson P, Cole BF, Chua BH, Price KN, Lindtner J, Collins JP, et al. Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report. Ann Oncol 2012; 23: 2852-‐8.
28. Van de Steene J, Soete G, Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: The missing link. Radiother Oncol 2000;55:263–272.
29. Ragaz J, Jackson SM, Plenderleith IH, et al. Can adjuvant radiotherapy improve the overall survival of breast cancer patients in the presence of adjuvant chemotherapy? 10-‐yr analysis of the British Columbia randomized trial. (Abstr.) Proc Annu Meet Am Soc Clin Oncol 1993;12:A40.
30. THE SIGNIFICANCE OF EXTRACAPSULAR EXTENSION OF AXILLARY LYMPH NODE METASTASES IN EARLY-‐ STAGE BREAST CANCER STELLA HETELEKIDIS, M.D.,*† STUART J. SCHNITT, M.D.,§ BARBARA SILVER, B.A.,* JUDITH MANOLA, M.S., BRUCE A. BORNSTEIN, M.D.,*† ASA J. NIXON, M.D.,*‡ ABRAM RECHT, M.D.,*‡ REBECCA GELMAN, PH.D.,* JAY R. HARRIS, M.D.,*† AND JAMES L. CONNOLLY, M.D.§ 2000 Elsevier Science Inc.
31. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ. Strategies for subtypesedealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the primary therapy of early breast cancer 2011. Ann Oncol Aug 2011;22(8):1736e47.
32. Hamamoto Y, Ohsumi S, Aogi K, Takashima S, Shinohara S, Nakajima N, et al. Identification of candidates for postmastectomy radiotherapy in patients with pT3N0M0 breast cancer. Breast Cancer 2013 July;20(3):218e22.
33. Karlsson P, Cole BF, Chua BH, Price KN, Lindtner J, Collins JP, et al. Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report. Ann Oncol 2012; 23: 2852-‐8.
34. Hunt KK, Ballman KV, McCall LM, Boughey JC, Mittendorf EA, Cox CE, et al. Factors associated with local-‐regional recurrence after a negative sentinel node dissection. Ann Surg 2012; 256: 428-‐36.
35. Post-‐mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-‐2 tumor and 1–3 axillary lymph node(s) metastasis
Yu-‐Li Su1, Shan-‐Hsuan Li1,2, Yen-‐Yang Chen1, Hui-‐Chun Chen3, Yen Tang4, Cheng-‐Hua Huang1, Fong-‐Fu Chou2,5, Shih-‐Chung Wu5, Kun-‐Ming Rau1,2,6 Radiol Oncol 2014; 48(3): 314-‐322.
36. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin
Oncol 2001; 19: 1539-‐69.
37. Pierce LJ. Treatment guidelines and technique in delivery of postmastectomy radiotherapy in management of operable breast cancer. J Natl Cancer Inst Monogr 2001; 30:117-‐124.
29
38. Kurtz J for the EUSOMA Working Party. The curative role of radiotherapy in the treatment of operable breast cancer. Eur J Cancer 38:1961-‐1974, 2002.
39. Truong PT, Olivotto IA, Whelan TJ, Levine M, for the Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional postmastectomy radiotherapy.CMAJ2004;170:1263-‐1273.
40. Kunkler I, Canney P, van Tienhovan G, et al. Elucidating the role of chest wall irradiation in ‘‘intermediate-‐risk’’ breast cancer: The MRC/EORTC/SUPREMO trial. Clin Oncol 2008;20:31– 34.
